Viewing nowCombinationDucor Tablet 30/2.5 mg
Fimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.

MFDS item code 202300081 · Approved 2023.01.06
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Pimasartan potassium is used when blood pressure control is insufficient with monotherapy in patients with essential hypertension. This medication helps effectively lower blood pressure and reduce the risk of cardiovascular diseases. Therefore, it is used for treating patients with hypertension who have difficulty controlling their blood pressure.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time every day (e.g., in the morning). It is recommended that the dose be adjusted using fimasartan before administering this medicine. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: Administer to patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: Administer to patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Elderly patients No initial dose adjustment is necessary for elderly patients 70 years of age or younger. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with 30 mg of fimasartan in this medicine. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
The safety and efficacy of this medicine have not been established in children and adolescents 18 years of age or younger.
This medication can cause serious harm to the fetus or newborn if taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. This medication should not be taken by individuals who are allergic to its active ingredient or similar substances, pregnant or breastfeeding women, patients undergoing kidney dialysis, those with moderate to severe liver dysfunction, patients with bile duct obstruction, diabetic patients with certain kidney diseases, patients with specific heart valve diseases, and patients in severe shock. Special caution is required for patients with hypovolemia, low salt levels, renal impairment, certain heart diseases, and elderly individuals when taking this medication. Side effects such as dizziness, headaches, facial or body swelling, urinary disorders, insomnia, and flushing may occur; if any unusual symptoms arise, consult a physician. Since this medication lowers blood pressure, hypoglycemic symptoms may appear when starting treatment or increasing the dosage, and it is advisable to have potassium levels checked periodically. When taken with other antihypertensives, diuretics, potassium supplements, specific antibiotics, and anti-inflammatory drugs, drug interactions may occur, so inform your doctor or pharmacist before taking. Taking this medication during pregnancy can cause serious issues for the fetus, so those planning to become pregnant or who are pregnant should consult healthcare professionals; it is also advisable to avoid taking it while breastfeeding. The safety and efficacy of this medication in children and adolescents under 18 years have not been sufficiently established, so its use is generally not recommended. Elderly individuals may respond more sensitively to this medication, so caution is required when taking it. Patients with severe liver dysfunction should not take this medication. In case of overdose, severe hypotension and cardiac problems may occur, so immediate medical attention is necessary. This medication should be kept out of the reach of children and transferred to other containers could alter its quality, so care should be taken.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that blocks light, preferably at a temperature between 1 and 30 degrees Celsius. This helps maintain the efficacy of the medication and prevents deterioration.
White, rounded square, film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Aprogen BioLogic Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.